There are moments in a policy fight when the noise stops working—when all the bluster, press conferences, and scare tactics run headlong into a judge who doesn’t care about any of it and just asks one simple question: what does the law actually say?
April 10 was that moment.
What followed was less a legal argument than a slow-motion collapse. The State’s lawyer looked like a man who brought a water pistol to a cattle drive—outmatched, outgunned, and increasingly aware of it. As the court pressed in, the case didn’t just weaken, it unraveled, failing the most basic requirement of any courtroom: say something with a straight face and back it up.
They couldn’t.
Because when it came down to brass tacks, the trifecta wasn’t even close. The facts weren’t on their side. The statute wasn’t on their side. And the Constitution sure as hell wasn’t on their side.
And a Texas judge noticed.
April 10, 2026 is going to stick. Not because it ends the fight, but because it exposed it. Strip away the politics, put the argument under oath, and the prohibitionist case folded like a cheap lawn chair in an August heatwave.
They didn’t just lose.
They got their hat handed to them.
A Travis County district court issued a Temporary Restraining Order halting enforcement of Texas’ latest hemp rules — a sweeping regulatory scheme that, in plain terms, attempted to rewrite the law without bothering to ask the Legislature. For an industry that has spent years navigating shifting goalposts, administrative improvisation, and the occasional outbreak of outright hostility, this order lands not merely as a procedural win. It’s a judicial rebuke — precise, methodical, and rooted in the first principles of administrative law.
What the State Tried to Do
The core issue, stripped of regulatory camouflage, couldn’t be simpler. Texas law defines hemp using a delta-9 THC concentration threshold of 0.3% on a dry weight basis. That’s the statute. That’s the line the Legislature drew. What DSHS attempted was to swap that framework for a “total delta-9 THC” or “acceptable hemp THC level” standard — a different chemical metric, a different legal universe, achieved entirely through rulemaking.
The court saw through the maneuver immediately. The rules, it found, “effect a substantive change in the governing law through rulemaking rather than implementing the statute as written.” That’s not a technical infraction. That’s a separation-of-powers problem — the kind courts take personally. Agencies are creatures of statute. They implement the law. They don’t rewrite it because they’ve decided they’d prefer a different answer.
Why the Court Moved Immediately
Temporary restraining orders don’t come easy. The standard demands a showing of probable success on the merits and imminent, irreparable harm. The plaintiffs cleared that bar with room to spare.
Enforcement of these rules, the court concluded, would fracture the entire hemp supply chain — manufacturing, testing, transport, retail — and effectively force businesses to shut down, abandon Texas, or face enforcement actions tied to standards no legislature ever authorized. The harm here isn’t hypothetical; it’s operational collapse. Supply chains break. Customer relationships vanish. Goodwill, once gone, doesn’t file a refund claim. These aren’t losses that can be tabulated and made whole later. They’re structural — and that’s precisely why the court found them irreparable.
A Statewide Industry, Not a Niche Dispute
One of the ruling’s more consequential passages is its recognition of scope. Processors, manufacturers, distributors, and retailers all operate within the same regulatory ecosystem. A flawed rule doesn’t stay politely contained — it propagates. Limiting relief to the named plaintiffs would have been a legal gesture, not a remedy. Effective relief required restraining enforcement broadly against similarly situated businesses, and the court said so plainly.
That finding matters beyond the immediate case. It signals that the judiciary understands the scale of what’s at stake here and isn’t prepared to treat a statewide industry like a zoning dispute.
The Public Interest Argument They Didn’t Expect to Lose
Perhaps the most quietly devastating section of the order is its treatment of the public interest — the argument opponents of the hemp industry have been running for years as if it were their exclusive franchise.
The court declined to rent it to them.
Instead, it recognized that consumers across Texas rely on hemp-derived products for legitimate, documented purposes: chronic pain, PTSD, sleep disorders, and as alternatives to alcohol and pharmaceuticals that carry their own considerable risks. Many of those consumers are veterans. The court also acknowledged what any honest policy analyst already knows: removing lawful products from the market doesn’t extinguish demand. It reroutes it — toward less regulated, less safe, or outright illicit alternatives. That’s not an industry talking point. That’s a judicial finding, and it will be difficult to walk back.
What the TRO Actually Does
The order is operational, not symbolic. The state is now restrained from enforcing the rules’ substitution of a “total THC” standard for the statutory delta-9 threshold, along with the enforcement mechanisms dependent on that framework — penalties, product embargoes, and license actions built on provisions the Legislature never passed.
The practical effect is a restoration of the status quo ante — the regulatory environment as it existed before March 31, 2026. Not perfect rules. Not permanent rules. Lawful ones. And for now, that’s enough to keep an industry running.
What Comes Next
A hearing on a temporary injunction is set for April 23, 2026, where the legal questions will be litigated more fully and the state will have its opportunity to defend the rulemaking. But the trajectory is already legible. The court has signaled skepticism grounded in statutory interpretation and administrative law doctrine — skepticism the state will struggle to overcome without retreating from its current position.
The strategic lesson here is simple enough. When the political process gets captured by narrative, the legal system becomes the venue of last resort. When the record is strong — when the facts, the statute, and the economic realities align — courts still function as a corrective. There’s a durable tendency in Texas politics to treat enforcement power as though it were synonymous with legal authority. This order draws a bright line between the two.
The state can regulate hemp. What it cannot do is redefine it. That distinction now sits where it always belonged: in the hands of the Legislature, not in the hands of whoever is running the rulemaking process on any given Tuesday.
A new lawsuit alleges Ohio used definitional trickery, interstate discrimination, and possibly an invalid veto process to hand a lawful hemp market to in-state marijuana licensees.
There are only so many ways a government can say, with a straight face, that it supports “regulation” while using the machinery of the state to crush lawful competition and reward politically favored insiders.
Ohio may have just found a new one.
A newly filed lawsuit by North Fork Distribution I, LLC, which does business as Cycling Frog, alleges that Ohio Senate Bill 56 does not merely regulate hemp. It effectively converts federally lawful hemp products into “marijuana” under Ohio law unless they are cultivated, processed, and sold through Ohio’s licensed marijuana system. In plain English, the complaint says Ohio tried to use state law to wall off its market, criminalize ordinary interstate commerce, and give the spoils to existing in-state marijuana operators.
That is not sound policy-making. That is market allocation with a badge and a press release.
The central allegation is straightforward. Congress legalized hemp in the 2018 Farm Bill and protected its interstate transportation. Ohio, according to the complaint, responded by narrowing the state definition of “hemp” so aggressively that many federally lawful hemp-derived products would be treated as “marijuana” once they enter Ohio. The result, the plaintiff argues, is that out-of-state hemp businesses face potential criminal exposure while Ohio’s licensed marijuana businesses receive an exclusive commercial advantage.
And the most revealing evidence may not be in the rhetoric of the complaint at all. It is in the state’s own legislative paper trail.
An attachment to the filing includes the Ohio Legislative Service Commission’s “Synopsis of Conference Committee Amendments,” which states that products falling outside the narrowed hemp definition “will be considered marijuana and sold exclusively in marijuana dispensaries.” That language is politically devastating because it strips away the usual camouflage. This was not merely about labeling, testing, or age gates. According to the complaint and the attached synopsis, Ohio structured the law so that products excluded from the new hemp definition would not disappear from commerce altogether. They would be redirected into a protected channel: licensed marijuana dispensaries.
That is the kind of detail that matters. It tells you what the law does, who it benefits, and who gets shoved overboard.
The lawsuit raises two major constitutional claims. First, it argues that S.B. 56 violates the Dormant Commerce Clause by discriminating against interstate commerce and favoring Ohio’s in-state marijuana industry over out-of-state hemp operators. Second, it argues that the law is preempted by federal law because Congress expressly protected the interstate transportation of hemp and removed hemp from the federal controlled-substances framework. Ohio, the complaint says, cannot simply relabel federally lawful hemp as “marijuana” at the border and pretend the Supremacy Clause does not exist.
That alone would make this an important case. But the complaint goes further.
It also alleges that S.B. 56 was never validly enacted in the first place because Governor Mike DeWine purportedly used the line-item veto in a manner forbidden by the Ohio Constitution. The filing contends that the governor did not merely veto appropriations items. He instead struck substantive policy language and tried to condition approval of the bill on that basis. If true, that is not a hemp technicality. That is a separation-of-powers problem. It means the case is not just about cannabinoid policy. It is about whether a governor can rewrite legislation under the guise of veto authority.
The complaint also does what strong injunction pleadings are supposed to do: it ties the constitutional injury to real-world harm. Cycling Frog’s verification affidavit says the company has substantial Ohio sales, inventory, contracts, retail relationships, and sunk investment tied to the market, and that it stands to lose a significant share of its business if the law takes effect. The company alleges that it cannot practically continue operating in Ohio without risking prosecution once federally lawful products are reclassified by Ohio as “marijuana.”
That matters because this is where many state officials and industry opportunists play games. They talk as though hemp operators are abstract villains and every product is a policy thought experiment. But companies are making payroll, signing leases, building supply chains, and operating in reliance on federal law and existing state frameworks. When a state abruptly rewrites definitions to favor a politically connected channel, the damage is not theoretical. It is immediate, concrete, and often irreversible.
This is why stakeholders in Texas should pay very close attention.
The tactic on display in Ohio will look familiar to anyone who has watched the hemp wars in other states. First comes the moral panic. Then the selective outrage. Then the carefully staged media narrative about “intoxicating hemp” destroying civilization. Then, once the public is softened up, comes the real play: not a neutral safety framework applied evenly across markets, but a commercial carve-up that favors incumbent interests and punishes disfavored ones.
That is what makes this case larger than Ohio.
If a state can redefine lawful hemp into contraband whenever the category becomes economically inconvenient, then the 2018 Farm Bill means whatever a hostile bureaucracy says it means that week. If a state can criminalize out-of-state products while granting in-state licensees exclusive control of the same market, then “regulation” has become a euphemism for economic protectionism. And if governors can carve up substantive law with an improvised theory of veto power, then the constitutional structure itself becomes just another casualty of the culture war.
There is also a political lesson here that the hemp industry needs to learn, and learn fast.
The people trying to destroy this market are rarely content with honest argument. They do not merely say they prefer a different regulatory structure. They inflate, smear, panic, and posture. They wrap commercial self-interest in the language of safety and then dare anyone to notice the transfer of wealth and power underneath. That game works only as long as no one reads the bill language, the committee synopsis, the enforcement hooks, and the market consequences together.
This lawsuit does exactly that.
It forces the question that every honest regulator should have to answer: if your concern is truly public safety, why are the products not banned across the board? Why are they being shifted into a preferred in-state system? Why do existing licensees get protection while interstate competitors get prosecution risk? Why does the law read less like a neutral regulatory framework and more like a franchise agreement for politically approved sellers?
Those are not rhetorical flourishes. They are the questions at the center of the case.
Ohio will, of course, say this is about health and safety. States always do when they are caught red-handed building a moat around favored economic actors. Courts will have to decide whether that explanation survives scrutiny. But on the face of the complaint, this is not a frivolous challenge or a performative filing. It is a serious constitutional case backed by a legislative paper trail and a concrete injury record.
National operators, retailers, compliance professionals, litigators, and investors should watch this closely. So should every Texas stakeholder who still thinks these state fights are isolated skirmishes. They are not. They are part of a coordinated pattern in which lawful hemp is tolerated when it is politically weak, demonized when it grows, and targeted for absorption or elimination when entrenched interests decide the market has become too valuable to leave alone.
That is the broader truth.
The fight is no longer just over cannabinoids. It is over whether law means what it says, whether interstate commerce still exists when a hostile state dislikes the product category, and whether politically disfavored businesses have any protection against governments that rewrite definitions to achieve outcomes they cannot defend openly.
The State Tried to Rewrite the Law Without Passing One
Filed tonight in Travis County, the hemp industry’s lawsuit against Texas regulators is not a routine administrative skirmish. It is a direct challenge to one of Austin’s most corrosive habits: when the Legislature declines to act, agencies act anyway.
That is the allegation — not as rhetoric, but as an unconstitutional structure the court must toss out like a drunk politician from The Cloak Room bar at last call.
To understand how Texas arrived at rules the legislature specifically declined to pass, you have to understand how power actually flows in Austin — and why that flow is far more complex, and far more lopsided toward one office, than most observers outside the Capitol appreciate.
The plaintiffs — trade associations, manufacturers, retailers — are not asking the court to referee competing visions of hemp policy. They are asking a more fundamental question: who governs? Because the constitutional process already answered it.
The Legislature passed Senate Bill 3. The Governor vetoed it. Two special sessions failed. Under the Texas Constitution, that means no new law. Full stop.
And yet, through rulemaking effective March 31, 2026, state agencies imposed the very restrictions the Legislature had declined to enact. The lawsuit is the industry’s answer to that maneuver. To understand why it happened, you need to understand the men behind it — and the institutional machinery one of them has spent eleven years building.
Because Dan Patrick has spent the better part of six years trying to destroy 8,500 licensed businesses, 53,000 jobs, and a $4.3 billion industry that the Legislature created, the Governor preserved, the courts protected, and the overwhelming majority of Texans want to keep — which raises the uncomfortable question of exactly whose Texas he thinks he’s governing.
The Most Powerful Man in Austin You’ve Never Fully Reckoned With
Most people understand that the lieutenant governor presides over the Texas Senate. What they don’t understand is what “presides” actually means in practice.
The man who once tossed THC gummies and cereal bites at reporters like a deranged game show host, then declared that regulated hemp shops were somehow a greater threat to Texas families than the opioids legally dispensed on every corner, has now — having failed four times through the front door — sent his agencies in through the window to do what democracy wouldn’t.
Under Senate rules, the lieutenant governor appoints every committee and every committee chair, refers all legislation to committee, controls the order in which bills come to the floor, and rules on all parliamentary questions at his own discretion. Bills don’t advance because they have the votes. They advance because Dan Patrick allows them to advance. The power of recognition is the power of life and death over legislation, and Patrick has exercised it without apology or restraint since taking office in 2015.
He has gone further than any of his predecessors were willing to go. Soon after assuming office, he persuaded the Senate to drop the threshold needed to consider a bill from two-thirds to three-fifths — a procedural change his predecessors Perry and Dewhurst never attempted because, as one political scientist put it, they had to work with senators on both sides. Patrick had no such compunction. He remade the chamber in his image. He then did something genuinely extraordinary in Texas political culture: he actively endorsed candidates in Republican Senate primaries — building a caucus that is not merely conservative but personally loyal to him, senators who owe their seats, in part, to his imprimatur.
But the lever most people miss entirely is Sunset.
The Texas Sunset Advisory Commission reviews state agencies and recommends to the legislature whether they should survive, be restructured, or disappear. In most cases, agencies are automatically abolished unless legislation is enacted to continue them. The lieutenant governor appoints half the Senate membership of that commission. Every agency director in Texas — every commissioner, every executive — knows that the man presiding over the Senate controls a significant portion of the body that can recommend their agency’s abolition. This is not a subtle pressure. It is an existential one. Agency heads who cross Patrick don’t just face legislative headwinds. They face the prospect of their agency’s continued existence becoming a question mark at the next Sunset cycle.
DSHS is not exempt from this calculus. In fact, it is deeply embedded in it.
Political scientists who study Texas government have noted that the lieutenant governor is considered as powerful as, and sometimes more powerful than, the governor. That assessment, already striking in the abstract, becomes clarifying when applied to the hemp saga — because the entire story of how we got to March 31 is, at bottom, the story of what happens when those two centers of gravity collide.
A Decade of Managed Coexistence, Then a Public Break
For most of their overlapping tenures, Abbott and Patrick maintained a working relationship premised on ideological alignment and careful avoidance of head-on collision. They are different creatures. Abbott is the cautious institutionalist — a former Texas Supreme Court justice who thinks in terms of legal sustainability, constitutional exposure, and long-game political risk management. Patrick is the former radio talk show host and Tea Party insurgent who thinks in terms of political dominance, culture-war momentum, and the next morning’s headlines. They needed each other and mostly behaved accordingly.
Hemp shattered that arrangement with unusual and very public ferocity.
Patrick had made SB 3 his signature priority of the 2025 session — a comprehensive ban on consumable hemp products containing THC. The Senate passed it 30 to 1 in March. He had staked his institutional credibility on it, worked his caucus, and by all accounts believed he had the governor’s quiet assurance that the bill would be signed. Then, just minutes before the veto deadline, Abbott killed it — without even calling Patrick first.
Patrick’s account of their private conversations was specific and damning. He claimed the governor had told him personally, in front of witnesses, “don’t worry about the bill” and had even asked Patrick’s staff lawyers for arguments he could use when signing it. Abbott’s team declined to engage the substance of those claims, which was itself a kind of answer.
The public rupture was immediate and raw. Patrick accused Abbott of wanting to “legalize recreational marijuana in Texas.” He held a press conference in which he described the governor’s late-night veto as a betrayal, questioned where Abbott had been all session, and demanded to know what had changed. It was the kind of performance that plays well on talk radio — which is, after all, where Patrick spent most of his adult life learning how to work a crowd. Abbott, operating in his natural register, issued a veto message that read like a legal brief: constitutional vulnerability, the Arkansas precedent where a similar ban had been enjoined in federal court for nearly two years, economic harm to tens of thousands of Texans who had invested in good faith under existing law.
Two men, two completely different concepts of what governance is for.
Abbott called two special sessions. Patrick refused to pivot toward regulation in either of them, driving legislation in both that mirrored the original ban. The Legislature sent Abbott nothing he could sign. At which point Abbott did what executives do when legislatures fail — he acted unilaterally, issuing Executive Order GA-56 on September 10, 2025, directing DSHS, TABC, and DPS to implement safety regulations: age verification, mandatory testing, labeling requirements, child-resistant packaging, enforcement coordination.
It was careful. It was targeted. And it was, critically, considerably less than what DSHS actually did with it.
The Technical Pivot That Changes Everything
At the center of the lawsuit sits what looks, at first glance, like a technical adjustment — a shift from a delta-9 THC standard to a “total THC” calculation.
It is anything but technical.
Texas law is explicit: hemp is defined, and legalized, based on delta-9 THC concentration not exceeding 0.3 percent. The Legislature chose that metric deliberately and wove it throughout the statutory framework governing commerce, testing, and legality. The new rules retain that definition on paper. Operationally, they replace it.
Regulators now mandate compliance with a formula that converts THCA into delta-9 THC equivalents — expanding the definition of “illegal” without touching the statute. Products lawful under the law become unlawful under the rule. That is not implementation. That is substitution. And in Texas constitutional law, those are very different things.
GA-56 authorized safety measures. It did not authorize a rewrite of the THC testing standard. It did not direct DSHS to adopt a total THC calculation that includes THCA — which has the practical effect of banning the majority of the hemp market that the Legislature had repeatedly declined to ban. That decision was DSHS’s own.
Which brings us back to Patrick, and to Sunset, and to the institutional ecosystem in which DSHS makes its decisions.
The agency didn’t go beyond GA-56 because Abbott told it to. DSHS went beyond GA-56 because it exists in a political environment where the most powerful actor in the building that controls its continued existence had made unmistakably clear what outcome he wanted. Patrick hadn’t merely lost a vote. He had been publicly humiliated by the governor, his signature priority killed in the final minutes of the session. Every career official in Austin understood the temperature.
The total THC formula was the only rulemaking decision that could simultaneously satisfy a governor’s executive order — technically, with careful reading — and deliver substantively the outcome the lieutenant governor had demanded and failed to get through the front door of the legislative process. DSHS chose the formula that closes the market. The rules effectively implement a federal total THC standard eight months ahead of the federal deadline, without the Texas Legislature having adopted that standard through statute. That tells you everything you need to know about whose clock the agency was watching.
A Regulatory Scheme That Collapses the Market
The complaint catalogs, in granular and unsparing detail, how these rules function in practice. The cumulative effect is not incremental regulation. It is market elimination.
Manufacturers cannot reliably source plant material because inputs must now satisfy a non-statutory metric before processing begins. Transport of hemp into Texas for processing is effectively prohibited. Testing requirements force reclassification of compliant agricultural products at later stages of production.
And then there are the fees — a regime that reads less like regulation and more like economic warfare. Manufacturer licenses jump from $250 to $10,000. Retail registrations climb from $150 to $5,000 per location. The agencies’ own record projects more than $200 million in annual economic impact while acknowledging minimal enforcement costs. That mismatch is not accidental. It is central to the plaintiffs’ constitutional claim: that these fees function as an unauthorized occupation tax, not cost recovery.
In a bitter irony, the original proposals were worse. During the public comment process, more than 1,400 comments poured in from businesses and consumers pushing back on rules that initially set manufacturer fees at $25,000 and retail fees at $20,000. Industry advocacy brought those numbers down. The fees that remain, while lower than the opening bid, still accomplish the same structural purpose — pricing out everyone but the most heavily capitalized players, if any survive at all.
Separation of Powers Is Not Optional
The petition’s most important section has nothing to do with THC calculations or licensing fees. It is the constitutional argument — and the one that will outlast this litigation regardless of outcome.
Texas agencies are creatures of statute. They hold no independent policymaking authority. Their mandate is to implement legislative decisions, not override them.
The lawsuit argues regulators crossed that line in every direction simultaneously. They imposed a compliance standard the Legislature rejected. They regulated upstream materials outside their statutory scope. They prohibited conduct the statute expressly permits. They built a fee and penalty structure that functions as economic prohibition dressed up as administrative process.
Taken together, these rules do not interpret the law. They produce a different one.
The plaintiffs frame it correctly: this is not a policy disagreement. It is a structural violation of the separation of powers — the kind that, if left unchallenged, licenses agencies to govern in perpetuity without legislative approval. The Legislature debated, voted, and failed to enact change — twice in regular session, twice in special session. In constitutional government, that sequence of events has a name: democratic outcome. The question the lawsuit poses is whether that outcome still means what it used to mean.
The Governor’s Role — and Its Limits
There is a second layer worth watching closely.
The lawsuit argues that regulators used GA-56 as a pretext to go further than the Governor himself directed. If that claim holds, the case becomes something more consequential than a check on bureaucratic overreach. It reinforces limits on executive implementation as well — and that has implications that travel well beyond this industry.
Abbott is not the villain of this story. His veto of SB 3 was constitutionally well-reasoned, politically courageous given the forces arrayed against him, and arguably the act that preserved the hemp industry’s right to fight this battle in court rather than simply cease to exist. His executive order, whatever its limits, was careful — drafted with an eye toward legal defensibility rather than ideological maximalism.
The problem is that careful executives issue careful orders into political ecosystems they do not entirely control. GA-56 entered an environment shaped by eleven years of Patrick’s institutional accumulation, an agency acutely aware of its Sunset exposure, and a moment of extraordinary political pressure from the most powerful legislator in the state. What came out the other end was not what Abbott put in.
The Real Stakes: Market Structure and Political Power
Strip away the legal architecture, and the stakes come into focus with uncomfortable clarity.
This is a fight over whether a lawful, multi-billion-dollar industry in Texas can be dismantled without a vote — and over whether the constitutional check that a governor’s veto represents can be circumvented by an agency willing to use rulemaking to accomplish what legislation could not.
If the rules stand, much of the current hemp market becomes economically or legally untenable. Manufacturers relocate. Retailers close. Supply chains fracture. The industry the Legislature created in 2019 — and repeatedly declined to dismantle — gets eliminated by administrative formula instead.
If the plaintiffs prevail, the decision does more than preserve the status quo. It establishes that agencies cannot achieve through regulation what they failed to secure through legislation. That precedent reaches far beyond hemp. Austin’s regulatory class, and the political actors who lean on it, know it.
The pattern here is not unique to this industry. Dan Patrick has spent eleven years building a Senate caucus personally loyal to him, controlling the procedural machinery that determines what gets a vote, appointing the oversight commission that reviews whether agencies survive, and relentlessly expanding the informal influence of his office beyond anything his predecessors claimed. When the Legislature failed to deliver his top priority and the governor’s executive order didn’t go far enough, the regulatory apparatus delivered what legislation could not. The agency understood its institutional incentives. It acted accordingly.
That is the dynamic this lawsuit is, at its deepest level, challenging.
What Happens Next
The plaintiffs are seeking immediate injunctive relief to halt enforcement while the case proceeds. The court’s first decision — whether to grant a temporary restraining order — will be the initial signal of how seriously it takes the separation-of-powers claims.
From there, this case will move fast. The issues are clean, the record is extensive, the economic consequences are immediate, and the political backdrop is impossible to ignore. Appellate attention is likely before the trial court finishes its work. The Texas Supreme Court’s pending ruling in Sky Marketing v. DSHS — which questions whether DSHS can reclassify hemp-derived cannabinoids through administrative action rather than legislation — could land at any moment and reshape the entire landscape.
Final Observation
This case is not about whether Texas should regulate hemp more aggressively. It is not about Dan Patrick’s sincerely held conviction that THC products harm children, nor about Greg Abbott’s equally sincere conviction that prohibition was legally indefensible. Reasonable people hold different views on all of it, and the Legislature is the proper place to resolve them.
That is precisely the point.
Four legislative opportunities came and went. The democratic process ran its course and produced an outcome — not the one Patrick wanted, but an outcome nonetheless. The question now is whether that outcome means what it used to mean, or whether it is simply the opening bid in an agency rulemaking process that delivers the same result anyway, steered by the informal gravitational pull of the most powerful office in the Texas Capitol.
In a constitutional republic, the answer has to be that elections and vetoes and failed special sessions mean something. This lawsuit intends to establish that they do.
Medicare just became the nation’s first large-scale, reliable buyer of hemp — provided you are old enough, sick enough, and compliant enough to qualify. Everyone else — the twenty-something vaping a delta-8 cart in Austin, the Hill Country soccer mom with a bag of sleep gummies — is staring down a federal crackdown capable of erasing most of the existing retail market within a year. That split screen is the essential fact of American drug policy in 2026: Grandma’s CBD has received its federal blessing, while corner-store delta-8 is being fitted for the gallows.
The $500 Olive Branch, and What It Actually Means
On April 1, the Centers for Medicare & Medicaid Services quietly activated a pilot program allowing certain seniors to receive up to $500 annually in hemp-derived products through participating provider groups. Don’t mistake this for a subsidy program or a reward card you swipe at the Buc-ee’s hemp counter. Beneficiaries cannot walk into their local shop, save the receipt, and bill Washington. Instead, CMS will reimburse organizations operating inside select Innovation Center models — ACO REACH, Enhancing Oncology, and LEAD — up to $500 per eligible patient, with those organizations controlling which products are furnished as part of clinician-guided care plans. The federal government is not subsidizing brands. It is commissioning a tightly controlled cannabinoid experiment on its own terms.
The strings attached are considerable. Products must be hemp-derived and remain within the 0.3 percent delta-9 THC limit established by the 2018 Farm Bill, along with a hard cap of only a few milligrams of total THC per serving. Inhalables, synthetics, and anything with obvious intoxicating potential are excluded. Certain patients — those with disqualifying conditions including some substance use disorders and serious pulmonary disease — are carved out entirely. Dollars flow to accountable care organizations and similar entities, not to beneficiaries directly, which means clinicians and administrators control the tap. For Texas seniors, particularly in rural communities, “legal hemp” is about to acquire a respectable institutional twin: doctor-approved, chart-notated, dispensed through credentialed intermediaries rather than the shop on the frontage road.
FDA’s Wink and Nod — and Who It Leaves Out
To prevent the pilot from colliding with existing law on its first day, the Food and Drug Administration issued a new enforcement memorandum focused on Medicare-linked hemp products. The agency has spent years insisting that CBD in food and supplements occupies an unresolved regulatory gray zone. Now it is signaling a narrow pocket of “enforcement discretion” — an official look-the-other-way — when CBD is dispensed under clinician guidance inside CMS models and meets strict safety, labeling, and potency standards.
That carve-out does not extend to the broader Texas hemp marketplace. Retail tinctures, gummies, beverages, and vapes sold directly to consumers remain burdened by the same unresolved FDA questions, patchwork state rules, and ever-present risk that a compliance misstep converts inventory into contraband. Even brands that have invested seriously in rigorous testing, GMP-style production, and responsible labeling gain no special status from the fact that CMS is quietly paying for distant cousins of their products. Washington has blessed cannabinoid use in a narrow, medicalized lane — and left the general market precisely where it was, except for one item buried in a shutdown bill that threatens to blow everything else up.
The 0.4mg Time Bomb
While the Medicare pilot is launching, a separate piece of federal policy is counting down. Buried in last year’s government funding package to end a shutdown, Congress rewrote the federal definition of “hemp” to impose a hard ceiling of 0.4 milligrams of total THC per finished container — in addition to the already-familiar 0.3 percent delta-9 THC by dry weight. Any hemp-derived cannabinoid product exceeding that threshold will, once the law takes full effect, no longer qualify as hemp at all.
The numbers involved are not abstractions. Lawyers and analysts tracking the change warn that the cap would disqualify virtually all existing full-spectrum and intoxicating hemp products, along with a meaningful share of mainstream CBD items that contain trace THC exceeding the 0.4mg floor across a full bottle. Trade groups and beverage-law specialists estimate that 95 percent or more of current ingestible hemp products are over the line. In Texas alone, estimates peg the hemp market at roughly $8 billion, supported by thousands of jobs in farming, processing, distribution, and retail — an industry that would be, in the words circulating through trade commentary, “effectively shut down” if the cap is enforced as written. What was packaged inside the Beltway as a fix to the “intoxicating hemp loophole” looks, from the I-35 corridor, like a controlled demolition of an industry Washington once invited people to build.
Texas: Fresh Off a Victory, Walking Into an Ambush
No state illustrates the whiplash more vividly than Texas. Earlier this year, a hard push to ban hemp-derived THC products — spearheaded by Lt. Gov. Dan Patrick, backed by substantial Republican leadership — ran headlong into a mobilized hemp industry and a governor who ultimately vetoed the ban. The fight was real: hearing rooms filled, phone lines lit up, and small business owners made the case that prohibition would gut a multi-billion-dollar market. When the veto ink dried, many Texas operators concluded they had bought themselves at least a few years of breathing room.
Then came the federal shutdown deal. Buried in that compromise is the 0.4mg cap that accomplishes, at the national level, almost exactly what the failed Texas ban would have accomplished within one state. Nearly all consumable hemp products with any meaningful THC content become unlawful — not just in Houston and Lubbock but in Boise and Buffalo. The same operators who spent months fighting Austin now find themselves on the receiving end of a Washington decision they had virtually no hand in shaping. The sense of ambush is not rhetorical. It is palpable in every industry conversation and in local coverage from San Antonio to Dallas.
A Split Screen Made for Political Conflict
The juxtaposition is difficult to ignore. On one side of the screen, Medicare dips a cautious institutional toe into hemp, allowing clinicians in select models to furnish carefully constrained CBD and low-THC products as part of structured care plans. On the other, Congress and federal agencies have redefined hemp in a way that treats nearly anything beyond a trace as beyond the pale. One program recognizes cannabinoids as legitimate tools for managing pain, sleep, and chronic conditions — provided they arrive small, boring, and physician-mediated. The other treats any cannabinoid product that people actually choose to buy as a loophole to be sealed.
For Texas officeholders, this creates a set of choices that will not stay quiet. Supporting the federal 0.4mg cap means endorsing a Washington compromise that threatens to dismantle an $8 billion in-state industry that their own voters just finished defending against a home-grown ban. Backing the Medicare pilot, on the other hand, means conceding that cannabinoids are legitimate medicine for the very population most likely to appear in Republican primary elections — which undercuts a good deal of the rhetoric used to justify state-level crackdowns. Trying to ignore the contradiction does not make it disappear. Washington is now setting the terms for a sector that Texas policymakers thought they had partially tamed on their own.
Two Experiments, One State on the Line
From a policy standpoint, the United States is running two concurrent experiments. In the Medicare pilot, CMS and its partners will gather data on whether clinician-guided hemp products reduce pain, improve sleep, or lower downstream costs in selected patient populations, using the $500 annual ceiling as both incentive and constraint. In the broader economy, the new hemp definition and 0.4mg cap will test how resilient an industry can be when its core products are redefined into illegality by a few lines in a funding bill nobody was watching closely enough.
For Texas, which embraced hemp as a politically viable middle ground when broader cannabis reform remained a bridge too far, the stakes of both experiments are anything but theoretical. Producers, processors, and retailers were told the rules: test your products, get licensed, pay your taxes, and you can build a durable business under state and federal law. Now they are learning that the most important rule was always subject to renegotiation in a distant capital, with local investment and livelihoods treated as acceptable collateral. Whether Texas responds to that reality with the same ferocity it brought to Austin, or accepts it as the price of playing in a federally defined market, will say a great deal about whose experiment this actually is — and who gets to survive it.
Rapper turns police raid into music… and wins on free speech Afroman just proved something loud and clear:
You can turn a police raid into a hit song — and win in court.
The rapper, best known for “Because I Got High,” came out victorious in a defamation lawsuit filed by seven Ohio sheriff’s deputies after he used footage of a 2022 raid on his home in a series of music videos.
FROM RAID TO RECORD
The whole situation started when law enforcement raided Afroman’s house on suspicions of drug activity and kidnapping.
They came in heavy…
Guns drawn
House searched
Property damaged
And found nothing.
No charges. No arrests. No case.
THEN HE DID WHAT ARTISTS DO
Instead of staying quiet, Afroman flipped the script.
He took home security footage of the raid and turned it into content — dropping viral music videos, including tracks off his “Lemon Pound Cake” project.
One clip even shows an officer distracted by a cake sitting on the counter — a moment that became internet gold.
THE LAWSUIT
The deputies didn’t find it funny.
They sued Afroman for defamation, claiming:
He damaged their reputations
They faced harassment after the videos dropped.
They deserved millions in damages
(Reportedly close to $4 million.)
THE VERDICT
The court didn’t buy it.
A jury sided with Afroman, ruling that his videos and music were protected under free speech, not defamation.
After the win, Afroman summed it up in true fashion:
“We did it… Freedom of speech.”
WHY THIS MATTERS
This case hits bigger than one rapper.
It’s about:
Free speech vs. law enforcement power
Art as protest
Who controls the narrative after a raid goes wrong.
Afroman didn’t just defend himself — he turned the system into content… and beat it at its own game.
Our BLAZED TAKE
Let’s be real…
They kicked in his door, found nothing, and then got mad when he made a song about it.
That’s not defamation —
that’s storytelling.
And now there’s a legal precedent backing it up. It was absolutely hilarious watching him on the stand last week absorbing everything the DA threw at Afroman, as he stood there in his USA flag suit and sun glasses, and he leaned right back into the prossicuter, throwing body shots, 1st Ammendment, then 4th Ammendment.
As a monthly practitioner of the 1st amendment we are most proud of you Afroman and would love to get you on the podcast.
As lawmakers move closer to cracking down on hemp-derived THC products, the alcohol industry is stepping into the fight—and surprisingly, they’re not calling for prohibition.
Instead, a major alcohol trade group is urging Congress to regulate hemp THC beverages rather than ban them outright, arguing that a structured framework would protect consumers while preserving a fast-growing market.
The push comes as federal lawmakers consider policies that could effectively wipe out the booming hemp beverage sector, which has exploded in popularity as an alternative to alcohol.
Regulation Over Prohibition
The alcohol industry’s position is simple:
Set clear rules
Enforce age restrictions
Require testing and labeling
Treat THC drinks more like alcohol than contraband
Their argument? A ban won’t eliminate demand—it will just drive the market underground.
A Billion-Dollar Battle
Hemp-derived THC drinks have quickly become one of the hottest segments in cannabis, appealing to consumers looking for a legal buzz without alcohol. But that growth has also put a target on the industry’s back.
With federal changes looming—including tighter definitions of THC that could outlaw many current products—the stakes are massive.
The Bigger Picture
This isn’t just about drinks—it’s about the future of hemp itself.
Regulators want control
Lawmakers are split between bans and oversight Industries—from cannabis to alcohol—are jockeying for position
And now, even Big Alcohol is signaling something the hemp industry has been saying all along:
Regulation works. Prohibition doesn’t.
Bottom Line
As the fight over hemp intensifies, one thing is clear—this isn’t a fringe issue anymore.
When the alcohol industry starts lobbying to protect THC products, you know the game has changed.
While out-of-state vendors are not directly bound by the Texas Department of State Health Services (DSHS) retail ban, ordering THCA flower into Texas after
March 31, 2026, carries significant legal and practical risks.
Retail Ban Scope: The new DSHS rules specifically prohibit the manufacture, distribution, and retail sale of smokable hemp products (like THCA flower) within the state of Texas.
Out-of-State Loophole: Because DSHS regulations primarily govern Texas-licensed businesses, some out-of-state operators may continue to ship to Texas. However, Texas law requires any business selling consumable hemp products to Texas residents to register with the state, which may lead many reputable vendors to stop shipping to avoid legal conflict.
Confiscation Risk: Law enforcement can seize packages they suspect contain illegal substances. Under the new “total THC” calculation effective March 31, most THCA flower will test above the 0.3% limit, allowing the state to classify it as illegal marijuana.
State vs. Federal Conflict: While THCA flower may be federally compliant under the 2018 Farm Bill (based on Delta-9 levels), Texas’s stricter “total THC” standard means these products can be treated as controlled substances once they enter the state.
Possession Status: Current DSHS rules target the sale and distribution, not the possession by individuals. However, since THCA flower is physically indistinguishable from illegal marijuana without lab testing, possession still carries a high risk of “legal scrutiny” or arrest.
The direct answer is a qualified yes, but with significant risks and requirements. The new DSHS rules primarily govern the manufacture, distribution, and retail sale of hemp products within the state of Texas.
Here is how out-of-state vendors are impacted:
DSHS Registration Requirement: Any online retailer based outside of Texas that sells consumable hemp products to Texas residents is still required to register with the DSHS.
Retail Sale Loophole: The Texas Supreme Court has previously upheld that while Texas can ban the manufacturing of smokable hemp in-state, it cannot necessarily ban the retail sale of smokable products manufactured elsewhere, provided they meet state testing and labeling standards.
The “Total THC” Conflict: The new rule changes the state’s calculation to Total THC (THCA + Delta-9). While an out-of-state vendor might be legal in their home state, once the product enters Texas, it may be classified as illegal marijuana if it exceeds the 0.3% Total THC limit.
Vendor Risks and Compliance Out-of-state vendors will likely fall into two categories:
Risk-Averse Vendors: Many major out-of-state brands are already announcing they will stop shipping THCA flower to Texas to avoid potential legal conflict with state authorities or to prevent their products from being seized by law enforcement.
Gray Market Vendors: Some smaller or less cautious vendors may continue shipping, relying on the fact that DSHS rules target businesses rather than consumer possession.
Summary of What Remains “Safe” for Vendors
Many featured vendors, may offer the most “legally secure” products to sell to Texans from out-of-state after March 31 include:
Hemp-derived Delta-9 Edibles: These are fully compliant because they are formulated based on dry weight and do not rely on the THCA-to-THC conversion math.
Tinctures and Topicals: These products are generally unaffected by the smokable ban.
CBD Products: Standard CBD oils and isolates remain legal under both state and federal frameworks.
As geopolitical tensions escalate around the world, a growing number of analysts and independent media commentators are warning about the potential for a “false flag” event — an attack carried out in a way that falsely blames another party (in this case, Iran); in order to justify war or political action.
The conversation has resurfaced following renewed military tensions involving Iran and the United States in early 2026. Some commentators believe that if the conflict expands, a dramatic incident blamed on a foreign adversary could be used to rally domestic support for deeper military involvement.
A Pattern of Suspicion in Modern Warfare
The concept of false-flag operations isn’t new. Throughout history, critics of governments and intelligence agencies have pointed to controversial events and covert operations as examples of how governments sometimes manipulate public perception during wartime. Independent commentators argue that when officials begin warning about potential terror attacks or external threats, those narratives can sometimes function as political messaging designed to prepare the public for major policy decisions.
While these claims remain highly debated and often controversial, they reflect a growing distrust among segments of the public toward government institutions, intelligence agencies, and mainstream media coverage of international conflicts. War Messaging and Public Opinion One concern raised by critics is that emotionally powerful events — especially attacks on civilians — can dramatically shift public opinion. Historically, major incidents have sometimes triggered rapid political unity behind military action.
According to critics of modern war policy, a shocking domestic attack blamed on a foreign power could instantly generate public support for expanded conflict or new emergency powers.
Whether those fears are realistic or speculative, the discussion highlights a broader issue: how modern governments communicate threats and how quickly public sentiment can change during moments of crisis.
A New Media Landscape
Unlike previous decades, today’s information ecosystem is far more decentralized. Independent media platforms, podcasts, and social media networks now challenge official narratives in real time.
This means that any major geopolitical event is likely to be scrutinized instantly by analysts, journalists, and citizen investigators around the world.
Supporters of this decentralized media environment say it increases transparency and accountability.
Critics argue it also makes it easier for misinformation and speculation to spread rapidly.
Staying Informed Without Fear
Experts generally advise the public to approach dramatic geopolitical claims carefully, especially during periods of rising international tension.
The best defense against manipulation — whether from governments, foreign actors, or viral misinformation — is critical thinking, reliable sourcing, and patience before drawing conclusions.
As global conflicts evolve, one thing remains certain: information warfare is now as powerful as traditional weapons, and understanding how narratives are shaped may be just as important as understanding the battlefield itself.
In case you missed it, a new op-ed in the Washington Examiner highlights a critical public-policy issue: the federal prohibition on intoxicating hemp products that Congress passed into law with bipartisan support last November must be fully implemented this year, without delay.
With the U.S. House Committee on Agriculture set to begin markup of the Farm, Food, and National Security Act of 2026 – also known as the Farm Bill – on March 3rd, the intoxicating hemp industry is pushing hard to keep these products on the market.
But as Diane Carlson writes, “the measure passed with a rare bipartisan supermajority of 76 senators. It reflected what harmed families, emergency physicians, leading public health and youth-serving organizations, law enforcement, regulators, and 39 state attorneys general, both Democrat and Republican, had already concluded: this loophole had become a national public-health crisis. It was causing unacceptable harm to children, families, and communities nationwide.”
Carlson, who is the co-founder and national policy director of One Chance to Grow Up, a nonpartisan, nonprofit organization that educates and advocates children’s interests in marijuana policy, goes on to note that “in the “Wild West” of the intoxicating hemp market, there are no age gates, no testing standards, no ingredient disclosures, no warnings. The only assured variable is predictable harm from those building businesses off targeting children and deceiving the public through “dupe” products and false claims.”
Background: A provision signed into law last November will end the nationwide unregulated sale of psychoactive Tetrahydrocannabinol (THC) products disguised as “hemp” or cannabidiol (CBD). These items have flooded gas stations, convenience stores and online marketplaces with gummies, vapes and drinks that can rival marijuana in potency and typically appeal to children. The prohibition is set to take effect this November, but the intoxicating hemp industry is seeking to delay implementation of the law.
The Problem: Since 2018, bad actors exploited hemp regulations to create unregulated, lab-produced intoxicants (gummies, vapes, drinks) with THC levels matching regulated marijuana markets but are sold without age gates, testing standards or ingredient disclosures.
The Harm: The consequences are real. The loophole has contributed to accidental child poisonings, emergency room visits, impaired driving incidents and serious mental health concerns.
Carlson writes “the intoxicating hemp free-for-all led to the rise of accidental child poisonings and injuries, ER visits and hospitalizations, impaired driving, and other serious physical and mental health effects, including acute psychosis that, for some, led to suicide.”
The Solution: The closure doesn’t ban hemp or eliminate CBD – it simply ensures intoxicating products can’t be marketed as “hemp” and sold in easily accessible stores and locations. Implementation cannot be delayed if we’re serious about protecting children and families.
“If a product can intoxicate, it should not be marketed as wellness ‘hemp’ and sold next to everyday candies, snacks, and drinks outside of a voter-approved marijuana dispensary.”
Congress acted. Now the law must take effect on schedule. Protecting kids from unregulated intoxicating products should not be controversial, it should be common sense.
The Texas hemp industry does not have a marketing problem. It has a credibility problem.
That distinction matters.
When legislators talk about “unregulated intoxicants,” when law enforcement conducts raids with television cameras in tow, when opponents describe the market as a public health emergency, they are not arguing about cannabinoids. They are arguing about discipline. They are arguing about whether this industry behaves like an adult.
Good Manufacturing Practice—GMP—is the answer to that argument.
GMP is not a logo. It is not a slogan. It is not a sticker on a window. It is a system. At its core, GMP means this: products are manufactured in a controlled, documented, repeatable way that ensures consistency, safety, and traceability. It requires written procedures. It requires training. It requires recordkeeping. It requires the ability to answer a simple question without hesitation: “How do you know this batch is what you say it is?”
If you cannot answer that question with documentation, you are not in a regulated market. You are in a hobby.
The federal framework for GMP in the United States exists already. The Food and Drug Administration enforces current Good Manufacturing Practice, or cGMP, standards for foods, dietary supplements, cosmetics, and pharmaceuticals. Dietary supplements, for example, are governed by 21 C.F.R. Part 111. Food facilities operate under 21 C.F.R. Part 117. These are not abstract rules. They cover sanitation controls, supplier verification, batch production records, equipment maintenance, complaint handling, and recall procedures.
Hemp-derived products sit in a complicated regulatory posture, but that does not mean they sit in a vacuum. The scientific principles of GMP apply whether a product contains vitamin C or a cannabinoid.
The core concept is control. Control of raw materials. Control of processes. Control of environments. Control of records.
Consider what that looks like in practice. A manufacturer sources distillate. Under a GMP system, that supplier is qualified. Certificates of analysis are verified and tied to lot numbers. Incoming material is logged. Storage conditions are documented. Production steps are written in standard operating procedures. Employees are trained and their training is recorded. Each batch is assigned a number. Finished goods are tested. Distribution records show where each lot was shipped. If a defect is discovered, there is a documented recall plan.
That is not bureaucracy. That is civilization.
Hemp is a plant. Plants bioaccumulate heavy metals from soil. They host microbes if improperly dried. They degrade if stored in humid environments. Cannabinoids oxidize. Residual solvents can remain if extraction is sloppy. None of this is scandalous. It is chemistry. GMP exists to manage these variables, not to eliminate business.
The uncomfortable truth is that parts of the hemp market grew faster than their infrastructure. Entrepreneurs moved at startup speed. Regulation moved at legislative speed. Public perception moved at cable news speed. Those timelines collided.
When opponents point to mislabeled potency, contaminated products, or products marketed without guardrails, they are not inventing physics. They are pointing to variance. Variance is what GMP is designed to reduce.
Here is the forward-looking reality: industries that survive scrutiny are industries that document themselves into legitimacy. The food industry did not always have Hazard Analysis and Critical Control Points. The pharmaceutical industry did not always have batch validation. They built those systems because crises forced maturity.
Hemp can build them proactively.
This is not about surrendering to overregulation. It is about seizing narrative control. An industry that can show documented SOPs, training logs, supplier verification, sanitation schedules, and traceable batch records is not “the Wild West.” It is a regulated commercial ecosystem waiting for consistent oversight.
Legislators respond to evidence. Regulators respond to structure. Courts respond to documentation.
GMP transforms debate. Instead of arguing in the abstract about “dangerous products,” the conversation becomes concrete: show the batch record, show the COA, show the sanitation log, show the training file.
When you can produce those documents without panic, rhetoric loses oxygen.
There is a deeper point here. Credibility is cumulative. It is built through systems, not speeches. If the hemp industry wants durable access to markets, capital, insurance, and mainstream retail partnerships, it must look and operate like an industry that expects to be around in ten years.
GMP is not glamorous. It is binders and databases. It is checklists and calibration logs. It is the quiet confidence of being able to say, under oath if necessary, “Here is exactly how we made this product.”
In a climate where fear-based narratives move faster than facts, the disciplined operator has an advantage. Documentation is not defensive. It is strategic.
Hemp does not need louder slogans. It needs better systems. The future of the industry will not be decided by how passionately it argues, but by how professionally it operates. Industries that master their processes earn the right to exist. Those that do not are regulated by people who assume chaos. Good Manufacturing Practice is not a burden. It is armor. And the companies that understand that first will shape what this market becomes next.
If you want to understand where the infused edible market is headed, do not look at flashy
billboards or exaggerated marketing copy. Look at the gummies.
The Blazed Magazine Gummy Challenge 2026 brought together some of the most ambitious
names in hemp-derived and cannabis-infused confections, from ultra-high potency heavy hitters
to carefully crafted, flavor-forward, low-dose experiences. Entries were evaluated across multiple
THC categories along with a dedicated mushroom category. Judges focused on flavor, texture,
consistency, ingredient integrity, onset time, and overall effect.
This year, the competition was exceptionally tight.
Mushroom Category Winner Muscimol Blue Crush by Spores MD
Taking the top spot in the mushroom category was Muscimol Blue Crush by Spores MD.
Unlike psilocybin products, muscimol is derived from Amanita muscaria and delivers a distinctly
different experience. Spores MD has positioned itself as a structured, formulation-focused brand
in a mushroom market that often lacks clarity. Their Blue Crush offering stood out for its clean
execution, consistent dosing, and balanced, calming effect profile.
In a category that can easily drift into novelty, Spores MD demonstrated discipline and product
maturity.
THC Categories
THC entries were divided into three potency tiers:
High THC 100mg+
Mid Range 50mg+
Standard Dose 10mg to 25mg –
Each tier was judged independently, acknowledging that a 200mg product serves a very different
consumer than a 10mg product.
High THC 100mg+ Winner
Looper, Mango Gelato
Looper’s Mango Gelato gummies entered the competition with striking potency numbers,
labeled at 100mg per gummy and 10,000mg per package.
It is important to clarify for readers that products in this high-dose hemp space often contain
blended cannabinoid formulations. The total milligram count may include a mixture of hemp-
derived THC isomers and other cannabinoids rather than 100mg of pure delta-9 THC alone. This
approach has become common in the federally compliant hemp market.
Looper has built a strong retail presence through smoke shops and online distribution, focusing
on bold flavors and intense effect profiles aimed at experienced consumers. Mango Gelato
delivered a pronounced tropical profile and a long-lasting, high-intensity experience that clearly
resonated in the 100mg+ division.
For high-tolerance consumers seeking maximum impact per serving, Looper secured the top
position.
50mg+ Winner Wyatt Purp, Lemon Bar
Wyatt Purp claimed first place in the 50mg+ category with its Lemon Bar entry.
The brand has developed a reputation for premium-style infused products that emphasize flavor
craftsmanship alongside cannabinoid formulation. The Lemon Bar gummy offered a bright citrus
profile with a clean finish and balanced sweetness.
On a personal note, the Wyatt Purp chocolates were my favorite products in the entire
competition. The chocolate was rich and smooth, with none of the artificial undertones that often
accompany infused confectionery. The effect was strong yet composed, delivering a euphoric and
comfortable experience rather than a jarring spike. It was a reminder that potency and pleasure
are not mutually exclusive.
Wyatt Purp demonstrated that elevated edibles can compete on culinary merit, not just milligram
count.
10mg to 25mg Winner T&T Roots, Peach and Guava
T&T Roots secured the top position in the standard-dose category with its Peach and Guava
gummies.
This potency range represents where most consumers operate day to day. T&T Roots focused on
flavor harmony and reliable dosing. The peach and guava pairing felt natural and layered rather
than artificially sweet. Lower-dose products leave no room to hide behind strength alone.
Execution matters. T&T Roots delivered.
Four Way Tie for Second Place
The THC competition was so competitive this year that four brands tied for second place:
The Haze Connect, Key Lime Pie
Fyre, Plum Vanilla Kush
3GCC, Blackberry
Freezo, Mimosa Mountain
The Haze Connect impressed with a dessert-forward citrus profile and a fast-acting formulation. Fyre balanced fruit and creamy vanilla undertones with a smooth cannabinoid blend.
3GCC, short for Gods 3rd Gen Craft Cannabis, leaned into a craft identity with a deep blackberry
profile and consistent texture. Freezo’s Mimosa Mountain, infused with live rosin, stood out for solventless appeal and terpene
presence rarely captured so clearly in gummy form.
Each of these brands brought a distinctive identity to the table, underscoring how far the edible
category has evolved.
Third Place
Endozondo, Citrus Peach
Endozondo earned third place with its Citrus Peach entry. Known primarily for its CBD roots,
Endozondo has expanded thoughtfully into broader cannabinoid formulations. Citrus Peach
offered bright flavor and a smooth onset that appealed to consumers seeking balanced, measured
effects rather than extreme potency.
What This Year’s Challenge Revealed
Several trends emerged from the 2026 competition.
Blended cannabinoid formulations continue to dominate the high-dose hemp market.
Flavor sophistication is rising, with dessert-inspired and fruit-layered profiles leading the way.
Live rosin and solventless infusions are carving out a premium niche within gummies.
Consumers remain divided between ultra-high potency seekers and those who prefer controlled,
moderate experiences.
Edibles are no longer a secondary category in cannabis and hemp. They are a primary innovation
lane. Brands are competing not only on strength but on refinement, consistency, and culinary
credibility.
The 2026 Blazed Magazine Gummy Challenge demonstrated that the bar has been raised.
And the category continues to mature.
Texas has a way of clarifying things. You can talk theory all day in a committee room, but sooner or later somebody’s boots hit the ground and you find out what the law actually means. That is where we are with federal cannabis policy right now—caught between a reform signal from the White House and the unmistakable sound of warehouse doors being kicked in.
In December 2025, President Donald Trump signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III. That may sound like a bureaucratic reshuffling, but anyone who has spent time navigating the Controlled Substances Act knows the difference is not cosmetic. Schedule I is the legal fiction that cannabis has “no accepted medical use.” Schedule III acknowledges medical value and relaxes some of the most punitive structural burdens, including the tax regime that has strangled legitimate operators under Section 280E.
That was the signal from Washington: modernization. Alignment. A tacit admission that pretending cannabis belongs in the same federal category as heroin has become an exercise in self-parody.
And then came the raids.
The South Carolina Shock
In South Carolina, state and federal authorities executed sweeping enforcement actions targeting THC distributors under what prosecutors called “Operation Ganjapreneur.” Warehouses were searched. Trucks were seized. Thousands of pounds of product were confiscated. The rhetoric was familiar: highly intoxicating products, threats to children, narcotics charges.
Federal participation reportedly included the Drug Enforcement Administration, reminding everyone that even in a moment of federal policy transition, enforcement muscle remains fully flexed.
That is not an abstract policy debate. That is inventory in an evidence locker and people in handcuffs.
If you are an operator in Texas, that story does not feel distant. It feels like déjà vu.
Texas Has Lived This
We know this movie in Texas. We have watched hemp retailers operate in good faith under statutory language derived from the 2018 Farm Bill, only to find themselves facing seizures based on disputed lab interpretations. We have seen regulators struggle to reconcile evolving cannabinoid science with statutes drafted before anyone outside a chemistry lab had heard of delta-8. We have watched prosecutors test the outer edges of ambiguity because ambiguity is where discretion lives.
The 2018 Farm Bill did not hide its language. Hemp and all derivatives, extracts, cannabinoids, and isomers under 0.3 percent delta-9 THC were removed from the Controlled Substances Act. Congress wrote it. The President signed it. Markets responded. If legislators later decided the consequences were broader than anticipated, that is a drafting problem, not a smuggling conspiracy.
As James Madison warned in Federalist No. 62, “It will be of little avail to the people that the laws are made by men of their own choice if the laws be so voluminous that they cannot be read, or so incoherent that they cannot be understood.” We are living in the incoherence he feared.
The Republican Family Argument
This moment is not a clean partisan fight. It is an internal Republican argument.
Some lawmakers have publicly suggested that the President was “poorly advised” to move toward Schedule III. Their objection is procedural: that rescheduling amounts to an end-run around the FDA’s drug approval framework. Research, they argue, can proceed without altering federal classification.
That position is not merely technical. It reflects a worldview that treats drug scheduling as a cultural boundary marker. If you move the line, you concede ground.
On the other side are voices arguing that rescheduling is simply catching federal law up to political and medical reality. Longtime Trump ally Roger Stone has publicly urged the move, framing it as both substantively defensible and politically savvy. Cannabis reform polls well. Voters across party lines support medical access. The states have already moved.
This is not a debate about botany. It is a debate about governance and narrative.
The Culture-War Reflex
When enforcement rhetoric lumps cannabis together with fentanyl and cartel trafficking, the public hears a simple story: drugs are drugs. But cannabis is not fentanyl. Hemp-derived THC products sold in storefronts are not clandestine meth labs run by transnational syndicates.
Agencies like the Federal Bureau of Investigation understandably focus on dismantling violent criminal networks. That mission is legitimate and necessary. The danger arises when the language of that mission bleeds into areas where regulation, not eradication, is the appropriate tool.
Texas humor has a way of cutting through this. If you treat a mesquite bush like it’s a forest fire, you end up calling in helicopters for a backyard barbecue.
Reform Must Survive Contact with Reality
An executive order is direction. A raid is consequence.
If Schedule III becomes the operative federal posture, enforcement priorities should reflect that transition. That does not mean anarchy. It does not mean ignoring bad actors. It means calibrating response to actual harm rather than political optics.
The lesson from South Carolina is not that reform has failed. It is that reform without alignment creates instability. Businesses do not operate well in twilight zones. Investors do not deploy capital where statutory interpretation shifts by press conference.
Texas has every reason to watch this carefully. Our Legislature, our regulators, and our law enforcement agencies will inevitably confront the same tension between federal signals and state statutes. We can choose clarity through legislation and transparent rule-making, or we can choose episodic enforcement theatrics.
As Sam Houston once observed, “A leader is one who helps improve the lives of other people or improve the system they live under.” Modernizing cannabis policy is not about indulgence. It is about improving a system that has long been riddled with contradiction.
The story unfolding right now is not whether cannabis will remain controversial. It will. The story is whether American law can align itself with reality without swinging from neglect to overreaction.
Policy is not what is announced at a signing ceremony in Washington. Policy is what happens when the warrants are served and the courtroom doors close.
That is where reform proves itself—or exposes itself as rhetoric.
The next chapter of this series will examine what Schedule III actually changes on the ground and whether it meaningfully restrains the enforcement machinery we just watched in motion.
Because in Texas, we do not judge policy by applause lines.
Texas does not have a marijuana industry. It has a hemp industry that Congress legalized in 2018 when President Donald Trump signed the Agriculture Improvement Act of 2018 into law. That statute removed hemp and “all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers” containing no more than 0.3 percent delta-9 THC from the Controlled Substances Act. It was not ambiguous. It was not an accident. It was bipartisan and it was intentional.
Texas responded. Farmers planted. Processors invested. Retailers signed leases. An entire supply chain emerged around what is now a six-to-eight-billion-dollar Texas hemp market. That number is not a fever dream. It reflects retail, wholesale, manufacturing, logistics, and the secondary economic effects of a rapidly scaling consumer sector. Whether one likes the products or not, this is not a hobby economy.
And now we are in a trade war with China.
That matters.
Because if the stated national policy is economic sovereignty, domestic manufacturing, and protecting American supply chains from foreign capture, then the enforcement posture toward hemp deserves scrutiny. Texas entrepreneurs who relied on the text of the 2018 Farm Bill are facing regulatory whiplash and criminal exposure in some jurisdictions. At the same time, there is growing national concern about Chinese-linked criminal networks operating illegal marijuana grows in states with loose licensing systems, and about foreign chemical supply chains that feed gray and black markets in synthetic cannabinoids.
These are separate phenomena. But politically, they are colliding.
The hard question is this: are we protecting American producers, or are we destabilizing them while foreign competitors and illicit networks fill the vacuum?
If aggressive enforcement and regulatory ambiguity suppress domestic hemp operators in Texas, the market does not vanish. Consumer demand does not evaporate because a press conference was held. Markets adapt. Supply shifts. If legitimate, tax-paying Texas businesses are squeezed, the logical beneficiaries are out-of-state actors, offshore chemical suppliers, and illicit networks operating beyond transparent oversight.
That is not conjecture. It is how markets behave.
The intoxicating hemp segment exists because Congress legalized hemp broadly and because chemists learned how to work within that definition. THCa flower, delta-8, and other hemp-derived cannabinoids did not emerge from a conspiracy; they emerged from statutory text and innovation. Whether lawmakers now regret the breadth of that language is a separate political debate. But regret does not rewrite history.
If the United States is serious about economic competition with China, then domestic agricultural and manufacturing sectors should be strengthened, not destabilized through inconsistent interpretation. Texas hemp businesses are American small businesses. They hire locally. They pay Texas taxes. They lease Texas property. They operate under state registration systems.
One can argue for tighter standards. One can argue for clearer labeling. One can argue for age restrictions or potency caps. Those are regulatory debates. But criminalizing ambiguity while foreign supply chains remain fluid is not economic nationalism. It is self-inflicted asymmetry.
The China narrative is powerful because it taps into real anxieties about supply chain vulnerability, intellectual property theft, and chemical precursor markets. But it becomes incoherent if domestic entrepreneurs are treated as expendable collateral damage in the same breath.
Here is the uncomfortable tension: President Trump legalized hemp. Texas built an industry on that legalization. Now, in the middle of an escalating trade conflict with China, enforcement uncertainty threatens to push market share away from transparent American operators and toward actors far less accountable to U.S. regulators.
If we are in an economic war, strategy matters. You do not weaken your own productive base while invoking sovereignty.
Texas is uniquely exposed in this debate because of the size of its hemp economy and the state’s political alignment with national trade rhetoric. A six-to-eight-billion-dollar market is not a rounding error. It is jobs in Houston warehouses, manufacturing equipment in Dallas facilities, retail payroll in San Marcos strip centers, and rural acreage planted with hemp instead of fallow fields.
The question is not whether reform is needed. The question is whether reform strengthens domestic producers or drives capital offshore.
Nationalism, if it means anything, must include coherent domestic policy. Otherwise it becomes theater.
The Texas Department of State Health Services has formally extended the emergency rules governing consumable hemp products through March 30, 2026, as reflected in the February 6, 2026 Texas Register. These rules—first adopted in October 2025—remain in effect without substantive change. No new restrictions were added. No permanent rules were finalized.
This matters because the state had a choice. It could have locked in final rules and forced the issue legally and politically. Instead, it chose to extend temporary authority. That is not an accident. It is a pause.
The emergency extension keeps the current guardrails in place, including age-based sales restrictions, while avoiding a permanent regulatory position that would invite immediate legal challenge and legislative backlash. In plain terms, the state is holding its ground without planting a flag.
What this action does not do is just as important. It does not settle the future of hemp regulation in Texas. It does not expand enforcement authority. It does not criminalize new conduct. It does not resolve disputes over testing standards, product categories, or agency overreach. It simply preserves the status quo—briefly.
That brief preservation is the opportunity.
Emergency extensions are breathing room, not absolution. They create time for the industry to show whether it can operate credibly under scrutiny or whether the state will feel justified in tightening the vise. Every regulator and elected official understands this distinction, even if they do not say it out loud.
This is the moment when voluntary compliance stops being a philosophical preference and becomes a strategic necessity.
Certified training programs, documented age-gating, truth in labeling, truth in testing, verified brands, and clean supply chains are no longer just internal best practices. They are evidence. They are proof points that can be shown to the Governor’s Office and to legislators who are still persuadable. They answer the only question that really matters right now: Can this industry govern itself responsibly if allowed to continue operating?
Everything done during this window will be noticed. Good conduct compounds. Bad conduct will be amplified and used as justification for permanent restrictions that will be far harder to undo. There is no private behavior in this environment. There is only behavior that strengthens the case for rational regulation, or behavior that hands opponents exactly what they want.
Texas has not slammed the door. It has left it cracked open.
Whether that crack becomes a stable regulatory framework or snaps shut into overreach depends on what the industry does next. This window is real. It is short. And it should not be squandered.
The continued use of emergency rule renewals, rather than adoption of final rules, is not accidental and it is not merely procedural housekeeping. It reflects a deliberate choice by the agency to avoid locking itself into a permanent regulatory position while legal, political, and policy variables remain unsettled.
Final rules carry consequences that emergency rules do not. Once finalized, they invite immediate judicial review on a fuller record, expose the agency to greater litigation risk, and signal institutional confidence that the policy is both lawful and durable. By contrast, emergency renewals preserve flexibility. They allow the agency to maintain interim guardrails while avoiding a definitive commitment that could be overturned, enjoined, or politically repudiated.
The repeated reliance on emergency authority is therefore a tacit acknowledgment that the regulatory environment remains unstable. It suggests that DSHS understands its position is being watched closely by courts, the Legislature, and the Governor’s Office, and that moving too aggressively or too permanently could backfire. Emergency renewals buy time. They keep the status quo intact without forcing a showdown.
Politically, this matters. The absence of final rules signals that the industry has not lost the argument, even if it has not yet won it outright. The state is not declaring the matter settled. Instead, it is holding space—narrow space, but real space—while broader questions about statutory authority, public safety, economic impact, and administrative overreach continue to percolate.
That pause creates what amounts to breathing room, and breathing room only has value if it is used deliberately.
From a strategic standpoint, this is the window in which the industry must demonstrate maturity, seriousness, and good faith. Everything being done now—certified compliance education, standardized training for owners and employees, verified brand programs, age-gating protocols, and documentation of best practices—is not just about internal improvement. It is evidence. It is proof of concept. It is the answer to the unspoken question regulators and legislators are asking: Can this industry govern itself credibly if given the chance?
This is particularly relevant for engagement with Greg Abbott’s office and with legislators who remain persuadable rather than hostile. Emergency renewals create space for education. They allow time to show—not merely assert—that the industry has taken concrete steps to address safety, youth access, product integrity, and transparency. They also allow elected officials to absorb that information without having to immediately defend a yes-or-no vote.
At the same time, the moment comes with discipline requirements. The industry should assume that everything it does is being observed—by regulators, by lawmakers, by opponents, and by the press. There is no such thing as a private experiment right now. Good behavior compounds. Bad behavior will be amplified and weaponized. Compliance efforts that are real, documented, and independently verifiable strengthen the case for reasonable regulation. Sloppy conduct, internal infighting, or opportunism weaken it.
Legally, the signal is equally clear. Emergency renewals suggest that the agency is aware its footing is not yet secure. That awareness creates leverage, but only if the industry continues to build a record showing that education, certification, and verification are not theoretical aspirations but operating realities. Courts care about facts on the ground. Legislators care about political risk. The Governor’s Office cares about both.
In short, emergency rule renewals are the state pressing the pause button—not out of generosity, but out of caution. The industry has been given time, not absolution. Used wisely, this period can materially improve the odds of a durable, lawful, and rational regulatory framework. Used poorly, it will be cited later as proof that the opportunity was squandered.
The work now is not defensive panic. It is methodical proof-building. And in this environment, proof has a way of moving people who were previously content to sit on the fence.
For years, kratom existed in a regulatory gray zone—debated, periodically regulated, but rarely confronted through full-scale state enforcement. That equilibrium broke on February 6, 2026, when the Texas Attorney General filed suit in Ellis County seeking an ex parte temporary restraining order, temporary and permanent injunctions, and civil penalties against two smoke shop operators accused of selling illegal kratom products .
The State’s opening claim is blunt and unambiguous:
“Kratom is addictive and deadly.”
According to the petition, Texas health officials and lawmakers are no longer dealing with traditional botanical kratom, but with what the filing describes as “potent and dangerous concentrations of synthetic alkaloids” that bear little resemblance to the plant historically consumed in Southeast Asia .
The lawsuit alleges that products sold at Smokey’s Paradise retail locations contained 7-hydroxymitragynine (7-OH) at levels that “significantly exceed[] the 2% statutory limit” imposed by the Texas Kratom Consumer Health and Safety Protection Act. In some cases, laboratory testing allegedly found 7-OH making up “96% of the tablet”—a concentration the State characterizes as “forty-nine times the legal limit” .
Even more consequential is the State’s allegation that several products contained mitragynine pseudoindoxyl, a compound the petition states “is not a natural alkaloid present in botanical kratom leaves” and “must be synthetically produced” . Under Texas law, the presence of synthetic alkaloids alone is sufficient to render a kratom product illegal.
The petition identifies specific branded products allegedly purchased by investigators and sent for independent laboratory testing, including Dozo Perks 7-OH tablets, 7OHMZ 7-OH tablets, 7Tabz 7-OH tablets, 7O’Heaven 7-OH liquid shots, and Tahi Mahji tablets .
The State does not frame these allegations as technical violations. Instead, it situates them squarely within an opioid-risk narrative. The filing describes 7-OH as “a potent mu-opioid receptor agonist with pharmacological properties similar to morphine and fentanyl” and warns that products containing concentrated 7-OH can cause “respiratory depression, physical dependence, and withdrawal symptoms characteristic of classical opioids” .
From a legal standpoint, the enforcement posture is as aggressive as the rhetoric. The Attorney General argues that when a statute is violated, courts need not weigh competing harms. Citing Texas precedent, the petition states that “the status quo can never be the continuing violation of a law,” and that the State’s “inability to enforce its duly enacted laws clearly inflicts irreparable harm” .
That framing matters. It allows the State to seek immediate injunctive relief without the delays typically associated with protracted litigation. In practical terms, it means retailers can be ordered to stop selling an entire product category before any final ruling on the merits.
For legislators, the lawsuit provides something equally valuable: a ready-made factual record. The petition assembles poison-center data, FDA warnings, DEA classifications, and laboratory findings into a narrative that recasts kratom not as an herbal supplement with compliance problems, but as an emerging synthetic opioid threat. Once that framing is adopted, legislative outcomes tend to follow.
The implications extend beyond kratom alone. Regulators do not evaluate retail compliance in isolation. Stores alleged to sell illegal synthetic products are more likely to be viewed as systemic risks, a perception that can spill over into inspections, licensing decisions, and enforcement priorities affecting other product categories, including hemp-derived THC.
The Ellis County case is therefore best understood not as an isolated dispute, but as a template. It shows how kratom enforcement is likely to proceed and how legislative debates will be shaped going forward. The State has moved past warnings and into injunctions, past regulation and toward elimination.
For an industry accustomed to regulatory ambiguity, the message is suddenly precise. The kratom debate has entered its endgame, and the first decisive move has already been filed in court.
Regulation Over Prohibition
A Billion-Dollar Battle
The Bigger Picture
Bottom Line
